Records containing: Recurrent Pancreatic Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-11-26A Phase II Study of the Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer
-
CLINICAL_TRIALS study record update · 2014-07-23Phase II Study of STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
-
CLINICAL_TRIALS study record update · 2014-06-11A Phase I, and Biologic Correlative Study of Erlotinib, in Combination With Cetuximab and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2014-05-30A First Time in Human Phase I Imaging Study of iRGD in Patients With Advanced Breast and Pancreas Cancer
-
CLINICAL_TRIALS study record update · 2014-05-19Phase IIA Trial Testing Erlotinib as an Intervention Against Intraductal Pancreatic Mucinous Neoplasms
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-04-02A Phase I Study of ABT-888 in Combination With Oxaliplatin and Capecitabine in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study of Sunitinib Malate and Standard Infusion Gemcitabine in Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase I Study of R04929097 in Combination With Gemcitabine in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-01-10An Open-Label, Non-Randomized Phase II Study of Alvocidib (Flavopiridol) in Combination With Docetaxel in Refractory, Metastatic Pancreatic Cancer (NCI #6366)
-
CLINICAL_TRIALS study record update · 2013-12-23Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas
-
CLINICAL_TRIALS study record update · 2013-12-05A Phase II Trial of AZD0530 in Previously Treated Metastatic Pancreas Cancer
-
CLINICAL_TRIALS study record update · 2013-11-25A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination With Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2013-11-20A Randomized Phase II Study of Bevacizumab (NSC# 704865) and Gemcitabine in Combination With Either Cetuximab (NSC# 714692) or OSI-774 (NSC# 718781) in Patients With Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2013-10-08A Phase II Study Of Triapine For Advanced Adenocarcinoma Of The Pancreas
-
CLINICAL_TRIALS study record update · 2013-09-30A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)
-
CLINICAL_TRIALS study record update · 2013-07-02A Phase II Study of BAY 43-9006/Gemcitabine for Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2013-06-05A Randomized Phase III Trial Of Gemcitabine Plus Bevacizumab (NSC#704865 IND#7621) Versus Gemcitabine Plus Placebo In Patients With Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2013-06-04A Phase 1 Study of Alvocidib (Flavopiridol) in Combination With Radiation in Locally Advanced, Non-Operable Pancreatic and Extrahepatic Bile Duct Cancers
-
CLINICAL_TRIALS study record update · 2013-06-04A Phase I Study of OSI-774 in Combination With Gemcitabine and Radiation in Locally Advanced, Non-Operable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2013-06-04A Phase II Study of Sunitinib Malate (SU11248, NSC #736511, IND #74,019) in Patients With Previously Treated Pancreatic Adenocarcinoma With Measurable Metastatic Disease Following Progression on Front-Line Gemcitabine-Based Therapy
-
CLINICAL_TRIALS study record update · 2013-02-28A Phase I Trial of Herceptin and Interleukin-12
-
CLINICAL_TRIALS study record update · 2013-01-25Phase I Study of a Recombinant Fowl Pox Vaccine rF-CEA (6D)/TRICOM Alone or With GM-CSF in Patients With Advanced CEA Expressing Adenocarinomas
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase II Trial Of Bevacizumab (NSC#704865) Plus Gemcitabine In Patients With Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2013-01-23A Phase I Study Of UCN-01 In Combination With Gemcitabine In Unresectable Or Metastatic Pancreatic Carcinoma
-
CLINICAL_TRIALS study record update · 2013-01-17Phase II Trial of CCI-779 in Locally Advanced or Metastatic Pancreatic Cancer